The assessment of side effects of health recommendations given to youth in general and children and adolescents with obesity.
Hebebrand
Johannes
J
D000293:Adolescent; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D002648:Child; D006293:Health Promotion; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D009478:Neuropeptide Y / Q000502:physiology*; D009765:Obesity / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D000077403:Orlistat; D055815:Young Adult
D019440:Anti-Obesity Agents; D007783:Lactones; D009478:Neuropeptide Y; D000077403:Orlistat
Obes Facts. 2010 Aug;3(4):267-72
20823691
Obes Facts. 2010 Aug;3(4):261-6
20823690
Obes Facts. 2010 Aug;3(4):245-51
20823688
Obes Facts. 2010 Aug;3(4):225-30
20823685
Obes Facts. 2010 Aug;3(4):239-44
20823687
Obes Facts. 2010 Aug;3(4):231-7
20823686
Obes Facts. 2010 Aug;3(4):252-60
20823689